| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 27.097 | 37.992 | 54.768 | 61.804 | 101.870 | 43.937 | 61.317 | 78.413 | 73.269 | 60.974 |
| Total Income - EUR | 21.266 | 372.615 | 73.040 | 124.167 | 110.684 | 46.118 | 61.350 | 89.539 | 72.686 | 60.612 |
| Total Expenses - EUR | 42.308 | 298.885 | 91.059 | 137.400 | 93.794 | 58.074 | 65.038 | 78.129 | 69.011 | 55.861 |
| Gross Profit/Loss - EUR | -21.043 | 73.730 | -18.020 | -13.233 | 16.890 | -11.956 | -3.687 | 11.410 | 3.675 | 4.751 |
| Net Profit/Loss - EUR | -21.936 | 70.010 | -18.741 | -14.437 | 15.821 | -12.235 | -3.933 | 10.708 | 3.001 | 2.452 |
| Employees | 4 | 5 | 6 | 5 | 5 | 4 | 4 | 4 | 3 | 2 |
Check the financial reports for the company - Alibi Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 254.340 | 104.120 | 130.323 | 54.979 | 112.801 | 105.685 | 99.536 | 95.508 | 88.661 | 83.979 |
| Current Assets | 74.192 | 190.308 | 95.352 | 152.523 | 105.327 | 60.466 | 70.794 | 70.979 | 70.635 | 47.825 |
| Inventories | 20.800 | 12.578 | 14.754 | 83.198 | 15.385 | 16.905 | 21.054 | 21.202 | 22.710 | 22.566 |
| Receivables | 52.411 | 45.012 | 20.763 | 20.672 | 20.369 | 22.297 | 29.080 | 29.741 | 24.572 | 5.655 |
| Cash | 981 | 132.718 | 59.835 | 48.653 | 69.573 | 21.264 | 20.660 | 20.036 | 23.354 | 19.604 |
| Shareholders Funds | 84.396 | 113.463 | 92.802 | 76.662 | 91.019 | 46.048 | 41.094 | 46.658 | 41.167 | 31.327 |
| Social Capital | 4.499 | 4.454 | 4.378 | 4.298 | 4.236 | 4.155 | 4.063 | 4.076 | 4.063 | 4.041 |
| Debts | 244.136 | 180.965 | 132.873 | 130.840 | 127.109 | 120.103 | 119.115 | 119.830 | 118.129 | 100.477 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 10.121 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "5610 - 5610" | |||||||||
| CAEN Financial Year |
5610
|
|||||||||
Comments - Alibi Srl